15 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
. Some of the raw materials that we anticipate will be required in our manufacturing process are derived from biologic sources. Such raw materials
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
candidates on schedule and could harm our results of operations and cause reputational damage. Some of the raw materials that we anticipate will be required … in our manufacturing process are derived from biologic sources. Such raw materials are difficult to procure and may be subject to contamination
S-1/A
d3axrr91h
13 Oct 22
IPO registration (amended)
10:51am
S-1
0hvfyn j82pl0y
23 Sep 22
IPO registration
4:12pm
DRS/A
fa4zd
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
7m51ph
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
52nsz
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
dt3tpcfxy sw
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
jfkmz3fhyetcnh8za9
7 Mar 22
Draft registration statement (amended)
12:00am
DRSLTR
fxo so0d5p12htk
4 Feb 22
Correspondence regarding draft registration statement
12:00am
DRS/A
j8qdzv
4 Feb 22
Draft registration statement (amended)
12:00am
DRS
17ztm9nwmyovvuvfqg
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next